Article Information
History
- May 4, 2022.
Article Versions
- Version 1 (January 28, 2022 - 10:38).
- Version 2 (February 2, 2022 - 04:43).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- 1Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA
- 2Center for Immunity and Immunotherapies, Seattle Children’s Research Institute, Seattle WA, USA
- 3Department of Biochemistry and Molecular Biology, Sealy Center for Structural Biology, University of Texas Medical Branch, Galveston, TX, USA
- 4Sealy Center for Structural Biology, University of Texas Medical Branch, Galveston, TX, USA
- 5Institute for Stem Cell & Regenerative Medicine, University of Washington, Seattle, WA, USA
- 6Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, WA, USA
- 7Department of Pediatrics, University of Washington School of Medicine, Seattle, WA, USA
- ↵*correspondence should be addressed to Bruce E. Torbett: bertorbet{at}uw.edu
Posted May 04, 2022.
Selective Ablation of 3’ RNA ends and Processive RTs Facilitate Direct cDNA Sequencing of Full-length Host Cell and Viral Transcripts
